CL
IRMD icon

CIM LLC’s iRadimed IRMD Stock Holding History

CIM LLC’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$737K Sell
7,712
-11
-0.1% -$1K 0.1% 115
2026
Q1 		$743K Sell
7,723
-591
-7% -$59.1K 0.11% 103
2025
Q4 		$809K Sell
8,314
-890
-10% -$76.4K 0.11% 107
2025
Q3 		$655K Sell
9,204
-53
-0.6% -$3.53K 0.09% 109
2025
Q2 		$553K Sell
9,257
-246
-3% -$13.5K 0.07% 110
2025
Q1 		$499K Sell
9,503
-499
-5% -$28K 0.07% 109
2024
Q4 		$550K Sell
10,002
-1
-0% -$53 0.08% 117
2024
Q3 		$503K Sell
10,003
-86
-0.9% -$3.97K 0.07% 115
2024
Q2 		$464K Buy
10,089
+561
+6% +$23.9K 0.07% 111
2024
Q1 		$419K Buy
9,528
+70
+0.7% +$3.09K 0.06% 114
2023
Q4 		$396K Buy
9,458
+658
+7% +$27.7K 0.06% 112
2023
Q3 		$390K Buy
8,800
+127
+1% +$5.9K 0.07% 111
2023
Q2 		$414K Sell
8,673
-295
-3% -$13.3K 0.08% 110
2023
Q1 		$353K Sell
8,968
-46
-0.5% -$1.67K 0.07% 119
2022
Q4 		$318K Sell
9,014
-40
-0.4% -$1.14K 0.06% 127
2022
Q3 		$251K Buy
9,054
+638
+8% +$22.2K 0.05% 134
2022
Q2 		$294K Sell
8,416
-109
-1% -$3.91K 0.06% 125
2022
Q1 		$354K Sell
8,525
-3,233
-27% -$150K 0.07% 114
2021
Q4 		$449K Buy
11,758
+294
+3% +$11.9K 0.08% 97
2021
Q3 		$437K Buy
11,464
+668
+6% +$22.7K 0.07% 110
2021
Q2 		$392K Buy
10,796
+1,475
+16% +$40.6K 0.06% 110
2021
Q1 		$261K Buy
9,321
+436
+5% +$10.4K 0.05% 136
2020
Q4 		$215K Buy
+8,885
New +$205K 0.04% 156

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIM LLC's IRMD Position: Q2 2026 in Review

CIM LLC reduced its iRadimed (IRMD) stake by 0.14% in Q2 2026, selling an estimated $1K and leaving 7,712 shares worth $737K. The position accounts for 0.1% of the portfolio, ranked #115.

CIM LLC first reported a position in IRMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $809K in Q4 2025. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • CIM LLC held 7,712 shares of iRadimed worth $737K as of Q2 2026.
  • CIM LLC sold 11 iRadimed shares in Q2 2026, an estimated $1K.
  • iRadimed made up 0.1% of CIM LLC's portfolio in Q2 2026, its #115 holding.
  • CIM LLC first reported a position in iRadimed in Q4 2020 and has held it in 23 quarters since.
  • CIM LLC's iRadimed position peaked at $809K in Q4 2025.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on CIM LLC's 13F filing for Q2 2026, filed 13 Aug 2026.